ArticleFrontiers in oncology2020

Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2.

Sara Galimberti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.